據歐盟食品安全局（EFSA）消息，2024年11月13日，歐盟食品安全局就活性物質精惡唑禾草靈（fenoxaprop-P-ethyl）的農藥風險評估發布同行評審。
經過評估，將精惡唑禾草靈作為苗后除草劑用在小麥、硬粒小麥、黑麥、小黑麥和大麥的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息，關注點已確定。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Austria and co-rapporteur Member State Finland for the pesticide active substance fenoxaprop-P-ethyl are reported. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012, as amended by Commission Implementing Regulation (EU) No 2018/1659. The conclusions were reached on the basis of the evaluation of the representative uses of fenoxaprop-P-ethyl as a post-emergence herbicide in wheat, durum wheat, rye, triticale and barley to control annual monocotyledonous weeds. The reliable end points, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.
經過評估，將精惡唑禾草靈作為苗后除草劑用在小麥、硬粒小麥、黑麥、小黑麥和大麥的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息，關注點已確定。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Austria and co-rapporteur Member State Finland for the pesticide active substance fenoxaprop-P-ethyl are reported. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012, as amended by Commission Implementing Regulation (EU) No 2018/1659. The conclusions were reached on the basis of the evaluation of the representative uses of fenoxaprop-P-ethyl as a post-emergence herbicide in wheat, durum wheat, rye, triticale and barley to control annual monocotyledonous weeds. The reliable end points, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.
